Pacalis Therapeutics is a privately held, neuroscience-driven biotechnology company focused on the optimization and development of next-generation therapies targeting prevalent mental health disorders.
Named after the Latin word for "peaceful", Pacalis is committed to addressing the substantial unmet medical need in mental health, with approximately 1 in 8 individuals worldwide affected by these conditions. We aim to transform outcomes by advancing scientifically rigorous, innovative treatments that challenge the current therapeutic landscape.
For more information, visit PacalisTherapeutics.com
Company Details
- Employees
- 3
- Founded
- 2023
- Address
- Melbourne, 3000, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- in medicinal chemistry.
- HQ
- Melbourne
Pacalis Therapeutics Pty Ltd Questions
Pacalis Therapeutics Pty Ltd's website is http://www.pacalistherapeutics.com
Pacalis Therapeutics Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/pacalis-therapeutics
Pacalis Therapeutics Pty Ltd has
3 employees.
View email and phone details for 3
employees at Pacalis Therapeutics Pty Ltd.
Pacalis Therapeutics Pty Ltd's industry is
Biotechnology Research
Pacalis Therapeutics Pty Ltd's top competitors are
Proxima Bio,
Inosi Therapeutics Pty Ltd,
Phrenix Therapeutics,
Misti,
Jumar Bioincubator,
Tessara Therapeutics,
Nutromics,
Immunosis,
Systematic Medicine,
Neurogen.
Pacalis Therapeutics Pty Ltd's categories are Biotechnology Research
Pacalis Therapeutics Pty Ltd's founding year is 2023
